Corrigendum to "Dasatinib ameliorates chronic pancreatitis induced by caerulein via anti-fibrotic and anti-inflammatory mechanism" [Pharmacol Res. 147 (2019) 104357].
Corrigendum to "Dasatinib ameliorates chronic pancreatitis induced by caerulein via anti-fibrotic and anti-inflammatory mechanism" [Pharmacol Res. 147 (2019) 104357]. Pharmacol Res. 2020 06; 156:104788.